Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

Université de Montréal

$40,000.00

Ultrasound phantom-free regularized local attenuation imaging

EF 2021-22

Résumé
Clinical ultrasound imaging provides different imaging modes for the purpose of diagnosis and therapy follow-up. Gray-scale B-mode imaging gives anatomy information, Doppler modes are used for measuring flow and tissue motion, and elastography modes allow assessing the mechanical property of tissues. Very recently, major ultrasound radiology manufacturers started releasing speed of sound, attenuation, and backscatter packages for tissue characterization and imaging. Those imaging modes enter into the category known as "quantitative ultrasound" (QUS) imaging, which aims providing a signature of a fundamental physical property of a tissue based on its interaction with propagating ultrasound waves. This application aims to further develop one of these QUS imaging methods, namely the quantification of the local attenuation known to change with pathology. The field of QUS imaging specifically aims to provide sub-resolution characteristics of acoustic scatterers or cells for the purpose of biological tissue characterization. One drawback of some of these methods is the requirement of a calibration phantom measurement to compensate for confounding effects of scanner and wave interaction characteristics with the insonified tissue. In this proposal, a phantom-free regularized local attenuation measurement method is proposed for applications in diagnostic imaging of liver diseases. The theoretical framework of the method relies on the assumption of similar wave diffraction effects at different frequencies within the bandwidth of the transmitted compression wave. Validation of the proposed imaging method will rely on computer simulations, in vitro gel phantom experiments and processing of clinical radiofrequency images. Robustness will be assessed by considering various conditions of background noise, homogeneous or heterogeneous tissues, attenuation contrasts, and presence or not of an inclusion (tumor) with different tissue characteristics. Ground truth measurements will be available for comparison with the proposed imaging method. Technological innovations will be made in line with product development priorities of our industrial partner, Siemens Healthcare.
Programme
Alliance Grants
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
561770-2021
Name nom
Cloutier, Guy
Department département
Génie biomédical, Institut de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
40000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
3
Application title
Ultrasound phantom-free regularized local attenuation imaging
Keyword
NSERC
Application summary
Clinical ultrasound imaging provides different imaging modes for the purpose of diagnosis and therapy follow-up. Gray-scale B-mode imaging gives anatomy information, Doppler modes are used for measuring flow and tissue motion, and elastography modes allow assessing the mechanical property of tissues. Very recently, major ultrasound radiology manufacturers started releasing speed of sound, attenuation, and backscatter packages for tissue characterization and imaging. Those imaging modes enter into the category known as "quantitative ultrasound" (QUS) imaging, which aims providing a signature of a fundamental physical property of a tissue based on its interaction with propagating ultrasound waves. This application aims to further develop one of these QUS imaging methods, namely the quantification of the local attenuation known to change with pathology. The field of QUS imaging specifically aims to provide sub-resolution characteristics of acoustic scatterers or cells for the purpose of biological tissue characterization. One drawback of some of these methods is the requirement of a calibration phantom measurement to compensate for confounding effects of scanner and wave interaction characteristics with the insonified tissue. In this proposal, a phantom-free regularized local attenuation measurement method is proposed for applications in diagnostic imaging of liver diseases. The theoretical framework of the method relies on the assumption of similar wave diffraction effects at different frequencies within the bandwidth of the transmitted compression wave. Validation of the proposed imaging method will rely on computer simulations, in vitro gel phantom experiments and processing of clinical radiofrequency images. Robustness will be assessed by considering various conditions of background noise, homogeneous or heterogeneous tissues, attenuation contrasts, and presence or not of an inclusion (tumor) with different tissue characteristics. Ground truth measurements will be available for comparison with the proposed imaging method. Technological innovations will be made in line with product development priorities of our industrial partner, Siemens Healthcare.